Filing Details

Accession Number:
0001104659-25-025194
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-18 19:07:35
Reporting Period:
2025-03-14
Filing Date:
2025-03-18
Accepted Time:
2025-03-18 19:07:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124524 Cryoport Inc. CYRX Pharmaceutical Preparations (2834) 880313393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247309 Robert Stefanovich C/O Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood TN 37027
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-14 10,000 $0.00 193,078 No 4 A Direct
Common Stock Disposition 2025-03-17 1,659 $6.29 191,419 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2025-03-14 25,000 $0.00 25,000 $7.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2032-03-14 No 4 A Direct
Footnotes
  1. Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.
  2. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
  3. 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.